OFVIX | VIVAX | OFVIX / VIVAX | |
Total Expense Ratio | 0.54 | 0.17 | 318% |
Annual Report Gross Expense Ratio | 0.54 | 0.17 | 318% |
Fund Existence | 9 years | 33 years | - |
Gain YTD | 10.459 | 6.724 | 156% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 249M | 195B | 0% |
Annual Yield % from dividends | 1.87 | 2.06 | 91% |
Returns for 1 year | 8.40 | 9.76 | 86% |
Returns for 3 years | 35.50 | 34.31 | 103% |
Returns for 5 years | 95.29 | 74.87 | 127% |
Returns for 10 years | N/A | 116.32 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VCBCX | 19.93 | 0.12 | +0.61% |
VALIC Company I Systematic Growth | |||
BSPPX | 746.63 | 2.99 | +0.40% |
iShares S&P 500 Index Investor P | |||
GQRPX | 18.52 | 0.02 | +0.11% |
GQG Partners Global Quality Equity Inv | |||
MRASX | 11.62 | -0.02 | -0.17% |
Cromwell CenterSquare Real Estate Inst | |||
CIOIX | 19.24 | -0.11 | -0.57% |
Causeway International Opps Inst |